Citadel Advisors’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.3M | Buy |
562,866
+351,071
| +166% | +$8.27M | ﹤0.01% | 1197 |
|
|
2025
Q1 | $5.09M | Buy |
211,795
+156,989
| +286% | +$3.77M | ﹤0.01% | 1740 |
|
|
2024
Q4 | $2.32M | Buy |
54,806
+51,736
| +1,685% | +$2.19M | ﹤0.01% | 2451 |
|
|
2024
Q3 | $136K | Sell |
3,070
-1,581
| -34% | -$69.9K | ﹤0.01% | 4789 |
|
|
2024
Q2 | $168K | Sell |
4,651
-22,311
| -83% | -$807K | ﹤0.01% | 4736 |
|
|
2024
Q1 | $1.16M | Sell |
26,962
-12,685
| -32% | -$547K | ﹤0.01% | 3034 |
|
|
2023
Q4 | $610K | Sell |
39,647
-4,647
| -10% | -$71.5K | ﹤0.01% | 3528 |
|
|
2023
Q3 | $607K | Buy |
+44,294
| New | +$607K | ﹤0.01% | 3540 |
|
|
2023
Q2 | – | Sell |
-775,792
| Closed | -$6.02M | – | 6521 |
|
|
2023
Q1 | $6.02M | Sell |
775,792
-1,215,681
| -61% | -$9.43M | ﹤0.01% | 1673 |
|
|
2022
Q4 | $38.5M | Hold |
1,991,473
| – | – | 0.01% | 552 |
|
|
2022
Q3 | $42.4M | Sell |
1,991,473
-131,378
| -6% | -$2.8M | 0.01% | 464 |
|
|
2022
Q2 | $28.9M | Buy |
2,122,851
+33,331
| +2% | +$454K | 0.01% | 629 |
|
|
2022
Q1 | $49.1M | Buy |
2,089,520
+356,338
| +21% | +$8.37M | 0.01% | 451 |
|
|
2021
Q4 | $46.3M | Buy |
1,733,182
+4,834
| +0.3% | +$129K | 0.01% | 512 |
|
|
2021
Q3 | $29.1M | Sell |
1,728,348
-10,345
| -0.6% | -$174K | 0.01% | 691 |
|
|
2021
Q2 | $22.2M | Buy |
+1,738,693
| New | +$22.2M | 0.01% | 890 |
|